| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/09/2013 | CN102106831B 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
| 01/09/2013 | CN102091042B Method for preparing monodisperse nanosphere medicine carrier |
| 01/09/2013 | CN102026626B Granulate comprising escitalopram oxalate |
| 01/09/2013 | CN102008926B Method for preparing starch microspheres |
| 01/09/2013 | CN101822645B Controlled-release recombinant human bone morphogenic protein-2 poly-L-lactic acid microspheres and preparation method thereof |
| 01/09/2013 | CN101816722B Wash-free antipruritic antibacterial gel with Chinese medicament components and preparation method thereof |
| 01/09/2013 | CN101815573B Method of producing emulsion or dispersion and food, skin external preparation and drug containing emulsion or dispersion obtained by the production method |
| 01/09/2013 | CN101786601B Preparation method of compound nano particle with Fe3O4/CoO core shell structure |
| 01/09/2013 | CN101636411B Interferon alpha 2a modified by polyethylene glycol, synthesis process and application thereof |
| 01/09/2013 | CN101606923B Stable controlled-release rasagiline transdermal patch and preparation method thereof |
| 01/09/2013 | CN101596320B Medicament for treating tumor and application thereof |
| 01/09/2013 | CN101524330B Micro emulsion drug carrying system and manufacturing method thereof |
| 01/09/2013 | CN101428009B Insulin intranasal inhalation powder spray |
| 01/09/2013 | CN101332191B Stable perindopril tert-butylamine salt tablets and preparation method thereof |
| 01/09/2013 | CN101232905B Oral preparation useful in measuring capacity to metabolize pyridine |
| 01/09/2013 | CN101227894B Rapidly disintegratable oral tablet |
| 01/09/2013 | CN101176791B Amino acid communicating with polyglycol as well as manufacturing method and usage thereof |
| 01/09/2013 | CN101019905B Medicine composition containing tribulus fruit furostanol saponin and application thereof |
| 01/08/2013 | US8349991 Amphiphilic polymers and methods of use thereof |
| 01/08/2013 | US8349894 Injections of lipophilic amphotericin B |
| 01/08/2013 | US8349888 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 01/08/2013 | US8349794 Reconstitution medium for protein and peptide formulations |
| 01/08/2013 | US8349363 Temperature responsive delivery systems |
| 01/08/2013 | US8349309 Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 01/08/2013 | US8349308 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof |
| 01/08/2013 | US8349307 Polymer conjugates of opioid antagonists |
| 01/08/2013 | US8349297 Topical formulations |
| 01/08/2013 | US8349294 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 01/08/2013 | US8349012 Intervertebral disc treatment devices and methods |
| 01/08/2013 | US8348974 Spinning solution composition, process for producing regenerated silk fiber using the composition, and regenerated silk fiber produced by the process |
| 01/08/2013 | CA2637569C Pharmaceutical compositions with enhanced stability |
| 01/08/2013 | CA2620343C Process for preparing antibody maytansinoid conjugates |
| 01/08/2013 | CA2569514C Oral preparations and process for production thereof |
| 01/08/2013 | CA2562081C Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability |
| 01/08/2013 | CA2559188C Hyaluronic acid-methotrexate conjugate |
| 01/08/2013 | CA2546115C Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives |
| 01/08/2013 | CA2531118C Multivalent carriers of bi-specific antibodies |
| 01/08/2013 | CA2530811C Zeolites for delivery of nitric oxide |
| 01/08/2013 | CA2513260C Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 01/08/2013 | CA2504608C Controlled release depot formulations |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2486838C Organic amine salts of glutamic acid derivatives and their application |
| 01/08/2013 | CA2470262C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/08/2013 | CA2468539C Delivery of medicaments to the nail |
| 01/08/2013 | CA2466148C Medical compositions for intravesical treatment of bladder cancer |
| 01/08/2013 | CA2466027C Branched polymers and their conjugates |
| 01/08/2013 | CA2428782C Medicine based on anti-hyperglycaemic microcapsules with prolonged release and its method of preparation |
| 01/08/2013 | CA2414064C Clear aqueous anaesthetic composition |
| 01/08/2013 | CA2385498C Method to enhance healing of sternum after sternotomy |
| 01/08/2013 | CA2377207C Combinations for introducing nucleic acids into cells |
| 01/08/2013 | CA2341352C Oral vaccine compositions |
| 01/08/2013 | CA2305681C Apoptosis-related compounds and their use |
| 01/08/2013 | CA2224702C Stable hydroalcoholic compositions |
| 01/05/2013 | CA2745267A1 Iron supplement composition |
| 01/03/2013 | WO2013003827A2 Macrogol 15 hydroxystearate formulations |
| 01/03/2013 | WO2013003593A1 Methods of use of hsp70 for increased performance or hsp70 related disorders |
| 01/03/2013 | WO2013003529A1 Method of forming encapsulated compositions with enhanced solubility and stability |
| 01/03/2013 | WO2013003507A1 Multifunctional agents |
| 01/03/2013 | WO2013003306A1 Pharmaceutical compositions for parenteral administration |
| 01/03/2013 | WO2013002969A1 Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents |
| 01/03/2013 | WO2013002636A1 Controlled release system |
| 01/03/2013 | WO2013002505A1 Tape-type fluorine preparation using a biodegradable polymer material, and method for producing same |
| 01/03/2013 | WO2013002382A1 Nicorandil-containing pharmaceutical composition |
| 01/03/2013 | WO2013002331A1 Pharmaceutical preparation integrated with microneedles for skin treatment |
| 01/03/2013 | WO2013002317A1 Solid oxidized glutathione salt and method for producing same |
| 01/03/2013 | WO2013001605A1 Composition for producing carbon dioxide |
| 01/03/2013 | WO2013001451A1 Vector for the release of an active agent which is photocleavable by irradiation in the visible |
| 01/03/2013 | WO2013001244A1 Polymer particles or nano-vectors and use thereof as a drug and/or diagnostic agent |
| 01/03/2013 | WO2013001167A1 Non-toxic compositions for decreasing the risk of cancer caused by oral microbes |
| 01/03/2013 | WO2013001124A1 Saccharide nanocompositions for vaccine release |
| 01/03/2013 | WO2013001073A1 A new stable anesthetic composition for reducing skin reactions |
| 01/03/2013 | WO2013001044A1 Method for preventing the unfolding of a (poly) peptide and/or inducing the (re- ) folding of a (poly) peptide |
| 01/03/2013 | WO2013000917A1 Topical ophthalmological pharmaceutical composition containing regorafenib |
| 01/03/2013 | WO2013000909A1 Topical ophthalmological pharmaceutical composition containing sorafenib |
| 01/03/2013 | WO2013000895A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | WO2013000876A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 01/03/2013 | WO2013000778A1 Applicator system for applying a viscous liquid to the human skin |
| 01/03/2013 | WO2013000391A1 Aripiprazole medicament formulation and preparation method therefor |
| 01/03/2013 | WO2013000227A1 Synthesized poly(lactic-co-glycolic acid) from biomass creatinine-catalyzed copolycondensation of lactic acid and glycolic acid |
| 01/03/2013 | WO2012154942A3 Ceramide anionic liposome compositions |
| 01/03/2013 | WO2012149255A3 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins |
| 01/03/2013 | WO2012149247A3 Tolerogenic synthetic nanocarrier compositions with transplantable graft antigens and methods of use |
| 01/03/2013 | WO2012143524A3 Bispecific antibodies against her2 and cd3 |
| 01/03/2013 | WO2012131104A3 Biodegradable compositions suitable for controlled release |
| 01/03/2013 | WO2012130941A3 Perfluorinated compounds for the non-viral transfer of nucleic acids |
| 01/03/2013 | WO2012122471A3 Compounds and methods of use in ablative radiotherapy |
| 01/03/2013 | WO2012119781A3 Novel lipids, phospholipids, phospholipid and lipid compositions and their use |
| 01/03/2013 | WO2012113907A3 Paper support and method of recovering biological material therefrom |
| 01/03/2013 | WO2012094620A9 Hydrophobic molecule-induced branched polymer aggregates and their use |
| 01/03/2013 | WO2012012546A3 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 01/03/2013 | WO2011141705A8 Novel cationic lipids and methods of use thereof |
| 01/03/2013 | WO2011121559A3 Stabilized antibody preparations and uses thereof |
| 01/03/2013 | US20130006350 Drug-delivery endovascular stent and method for treating restenosis |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005834 Pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin |
| 01/03/2013 | US20130005833 Photo-responsive supramolecular hydrogels |
| 01/03/2013 | US20130005832 Silky-feeling non-aqueous structured composition |
| 01/03/2013 | US20130005831 Rapidly dissolving pharmaceutical compositions comprising pullulan |
| 01/03/2013 | US20130005829 Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom |
| 01/03/2013 | US20130005763 Sustained-release solid preparation for oral use |